[ad_1]
(ANSA) – ROME, MAY 02 – “Proceeding with these rhythms will be
possible to start the first human trials starting in July. “
Then the medical director of Spallanzani of Rome, Francesco
Vaia, about the next Covid 19 vaccine
Tested at the Institute of Infectious Diseases in Rome.
“If the first tests are successful, they will lead to 2021
administration of the vaccine in large numbers of people to
risk and, I hope, demonstrate its effectiveness “has
Vaia added. “Unlike traditional vaccines, vaccines
genetics does not use an inactive microorganism or part of
but the gene that encodes the antigen of the microorganism
that you want to neutralize, “explains Vaia. In this case, a
What has been learned: the gene that encodes will be used
the spike protein that allows the virus to enter the
the cells. This gene once entered the cells of the
organism, induces the production of proteins which in turn
stimulates the immune response against the coronavirus.
RESERVED REPRODUCTION © Copyright ANSA
[ad_2]
